ArticleDiabetologia2024

Phenotype-based targeted treatment of SGLT2 inhibitors and GLP-1 receptor agonists in type 2 diabetes.

Pedro Cardoso et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.